Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy |
| |
| Authors: | Aditya Kelkar Poonam Gandhi Winfried Amoaku Jai Kelkar Shreekant Kelkar Priyanka Raut Rachana Shah |
| |
| Affiliation: | aNational Institute of Ophthalmology, Pune, India;bQueens Medical Centre, Nottingham, UK |
| |
| Abstract: | We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge, this is the first reported case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal CSC.Key words: Hemorrhagic macular infarction, Intravitreal bevacizumab, Central serous chorioretinopathy |
| |
| Keywords: | |
|
|
